Tesamorelin 10mg: GNRH Analog (COA - Second Image)
Research Use Disclaimer:
All peptides offered by Prime Peptides are strictly intended for laboratory research purposes only. These products are not approved for human consumption, medical use, therapeutic applications, or diagnostic procedures. By purchasing or accessing information on this site, you acknowledge that it is your responsibility to comply with all applicable local, provincial/state, and federal laws and regulations regarding the handling, use, and storage of research chemicals and peptides. Prime Peptides assumes no liability for misuse, improper handling, or application of any products.
Research Profile
See product status
A concise product record covering the stated research format and supporting batch documentation.
- Compound
- —
- Stated amount
- —
- Format
- —
Access the current Certificate of Analysis index and batch-specific verification records.
Open COA index ↗Tesamorelin (also known as Egrifta™, TH9507) is a synthetic growth hormone-releasing hormone (GHRH) analog consisting of 44 amino acids. It is a modified version of natural GHRH with a trans-3-hexenoic acid substitution at the N-terminus, which enhances stability and half-life. FDA-approved in 2010, it is the only GHRH analog indicated for reducing excess abdominal fat in HIV-associated lipodystrophy.
Scientific Background
Tesamorelin is based on the endogenous GHRH sequence with a trans-3-hexenoic acid modification at the N-terminus.
This structural adjustment improves:
-
Peptide stability
-
Receptor binding affinity
-
Protection from enzymatic degradation
-
GH secretory potential
In preclinical research, Tesamorelin has been shown to influence:
-
Pulsatile GH release
-
Circulating IGF-1 levels
-
Lipid-metabolism regulation
-
Fat-oxidation pathways
-
Endocrine feedback loops
Because of its robust GH-axis activity, Tesamorelin is one of the most potent GHRH analogues used in scientific studies.
Research Areas of Interest
All information below is intended strictly for scientific, laboratory, and in-vitro research only.
1. Growth Hormone Secretion & Endocrine Signaling
Tesamorelin is widely studied for:
-
GH pulse amplitude and frequency
-
Receptor-mediated activation of pituitary somatotrophs
-
GH/IGF-1 axis dynamics
2. Lipid Metabolism & Fat-Reduction Pathways
Researchers evaluate Tesamorelin’s influence on:
-
Visceral-fat metabolism
-
Lipolytic signaling
-
Triglyceride-related pathways
3. IGF-1 Modulation & Cellular Growth Studies
Tesamorelin is used to explore:
-
IGF-1 expression changes
-
Nutrient-partitioning models
-
Protein-synthesis signaling
4. Pituitary & Hypothalamic Interaction Models
Research includes:
-
Receptor-driven GH release
-
Neuroendocrine-axis regulation
-
Comparative studies with CJC-1295 and GRF analogues
5. Comparative GHRH Research
Tesamorelin is frequently compared to:
-
CJC-1295 DAC
-
CJC-1295 no DAC (Mod GRF 1-29)
-
Sermorelin
-
Hexarelin and Ipamorelin (GHRPs)
All findings come from preclinical or in-vitro experimental models.
Molecular Profile
-
Peptide: Tesamorelin
-
Type: Synthetic GHRH analogue
-
Sequence Length: 44 amino acids
-
Modification: Trans-3-hexenoic acid at position 1
-
Molecular Weight: ~5,120 Da
-
Form: Lyophilized powder
-
Purity: ≥ 98% (HPLC tested)
Storage & Stability
-
Store lyophilized peptide at –20°C
-
Protect from heat, moisture, and light
-
Use reconstituted peptide promptly or store per lab guidelines
-
Avoid repeated freeze–thaw cycles
Each 3ml vial is formulated with 10mg of highly purified (>99%) lyophilized Tesamorelin, produced in sterile environments that meet research-grade standards. Prime Peptides validates every batch through third-party laboratory testing to ensure exact molecular composition, stable peptide structure, and consistent results suitable for a wide range of experimental designs.
Documentation: View the matching Certificate of Analysis
Research Use Disclaimer:
All peptides offered by Prime Peptides are strictly intended for laboratory research purposes only. These products are not approved for human consumption, medical use, therapeutic applications, or diagnostic procedures. By purchasing or accessing information on this site, you acknowledge that it is your responsibility to comply with all applicable local, provincial/state, and federal laws and regulations regarding the handling, use, and storage of research chemicals and peptides. Prime Peptides assumes no liability for misuse, improper handling, or application of any products.Lab Report
Research Use Disclaimer
Research Use Only: All products offered are intended strictly for laboratory research purposes. Products are not for human consumption and are not intended for diagnostic, therapeutic, or medical use. By purchasing from our website, customers confirm they are qualified researchers or laboratories and understand the intended research-use designation.
Related Compounds
GH 120iu: 12iu x 10 Vials
DSIP 5mg: Delta Sleep-Inducing Peptide
Ipamorelin 5mg Nasal Spray: 100mcg per Spray
